Efficacy and Safety of SH T00660AA in Treatment of Endometriosis

• Status: Completed
• Trial end date: 2006-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to demonstrate safety and efficacy of SH T00660AA compared to placebo in the treatment of endometriosis

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bayer

Criteria

Inclusion Criteria:

• Female patients with endometriosis-associated pelvic pain

Exclusion Criteria:

• Pregnant or lactating women

• history or suspicion of hormone dependent tumor

• therapy resistant endometriosis

• need for primary surgical treatment

• any other conditions which forbid the participation.